Cerebras Round-Trips to Its $185 IPO Price as the Margin Defense Falls Flat
CBRS is down 20.01% over 24 hours to $185.80 — within pennies of the $185.00 price Cerebras sold shares at six weeks ago, erasing the entire post-IPO premium. The trigger was its first public earnings: a clean revenue beat buried under guidance cutting core gross margin to 36-38% next quarter from 47%. CEO Andrew Feldman spent Wednesday calling the guidance misunderstood, blaming an infrastructure bottleneck rather than weak demand, but the explanation didn't slow the selling. A lockup freeing roughly 28 million insider shares this week is adding supply into the weakness.
Mover Brief
Back to the IPO Price
Cerebras priced its IPO at $185.00 a share on May 13, then opened at $350 and closed its first session up 68% at $311.07, briefly worth roughly $95 billion. Six weeks later $CBRS is back at $185.80 — essentially the exact price it sold shares at. The entire post-IPO premium is gone.
The Hyperliquid perp is down 20.01% over the last 24 hours as the spot name retests its listing floor, with $62 million in perp volume changing hands while it happened. This is the rare clean round trip: a stock that ran +68% on debut day handing all of it back to the same number it priced at.
The Margin Defense Didn't Land
The trigger was Cerebras' first earnings report as a public company. The top line was never the problem: GAAP revenue hit $193.4 million, up 94% year over year, with core gross margin at 47%. The guidance was. Management called for Q2 core gross margin of 36-38% and full-year margin of just 38-41%, a sharp step down from the 47% it just printed, with operating margins guided to stay deep in the red.
CEO Andrew Feldman spent Wednesday arguing the market misunderstood the guidance: the compression is an infrastructure bottleneck, not weak pricing or demand. To fill a rush of orders, Cerebras is temporarily leasing back systems from a large customer while it builds out its own data centers — a drag CFO Bob Komin pegged at 10 to 15 points of margin this year. "Buildings are the limiting factor," Feldman said. The explanation is coherent. It also didn't stop the stock from sliding straight through its IPO price the next session.
A Lockup Into the Weakness
The timing made it worse. Per the prospectus, roughly 28 million Class A shares held by directors, officers and non-employee holders became eligible to trade on the second session after Tuesday's report — meaning fresh insider supply unlocking exactly as the bid was already thin.
A margin scare plus an early lockup window is a textbook setup for an air pocket. With sentiment already negative on the print, there was no shortage of motivated sellers and not much underneath them, which is roughly what the tape delivered down to the $185 listing price.
The Standoff
This is not a demand story coming apart. The $20 billion-plus, 750MW OpenAI commitment and a new AWS inference partnership are still on the books, full-year revenue is guided to $855-865 million (up roughly 69%), and the company sits on about $3.3 billion in cash after the raise. Mizuho and Wedbush actually nudged estimates higher after the call.
The bear case is simpler: you are paying a premium multiple for a chipmaker running negative operating margins whose gross margins won't normalize until the leaseback unwinds — against Nvidia printing in the mid-70s. Until margins inflect or the unlock supply clears, $185, the IPO price, is the line that matters. Hold it and the round trip looks like a reset; lose it and the next buyers are all underwater from the offering.
Sources & Provenance
Citations below are preserved as structured Postgres source rows for this brief.
Citations Preserved
7
Reference links carried forward from the published mover record.
Original Signal
Open source tweetMarket Route
Direct route preserved for readers who want to inspect the tracked Hyperliquid market behind this archive entry.
Already onboarded? Open tracked market- 1Cerebras Q1 2026 results (SEC Form 8-K)sec.gov
- 2StockTitan: Cerebras Q1 revenue rises 94% to $193.4M, Q2 margin guidestocktitan.net
- 3CNBC: Cerebras falls after forecasting shrinking margin in first report since IPOcnbc.com
- 4CNBC: CEO says margin forecast was 'misunderstood' as stock plummetscnbc.com
- 5Benzinga: Cerebras Q1 2026 earnings call transcriptbenzinga.com
- 6CNBC: Cerebras begins trading on Nasdaq after IPOcnbc.com
- 7Cerebras: IPO pricing press releasecerebras.ai
This content is for informational purposes only and does not constitute financial advice. Trading perpetual futures involves substantial risk of loss.
Trade CBRS on Hyperliquid
Use referral code HIPERWIRE for 4% off trading fees on your first $25M in volume.
Live Market Metrics
Monitor real-time open interest and funding for CBRS.